The pro-inflammatory phenotype of microglial cells is also characterized by the increased release of IL-1β and TNF-α, two master regulators of inflammation widely implicated in the pathogenesis of CNS disorders, that share the same kinetics of release [43, 44]. Here, IL1B is linked to central nervous system disorder.